GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,011,000 | -7.8% | 1,095,810 | 0.0% | 0.21% | +20.5% |
| Q1 2022 | $37,959,000 | +40.8% | 1,095,810 | +19.0% | 0.17% | +69.3% |
| Q4 2021 | $26,952,000 | -8.9% | 920,810 | -20.7% | 0.10% | -16.5% |
| Q3 2021 | $29,580,000 | +12.6% | 1,160,900 | +54.8% | 0.12% | +6.1% |
| Q2 2021 | $26,265,000 | -14.1% | 750,000 | 0.0% | 0.11% | -39.7% |
| Q1 2021 | $30,563,000 | +41.1% | 750,000 | +50.0% | 0.19% | +44.3% |
| Q4 2020 | $21,655,000 | – | 500,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |